Phenytoin application in radiation induced dermatitis
Phase 2
- Conditions
- Breast Cancer.Malignant neoplasm of breast
- Registration Number
- IRCT2012070710205N1
- Lead Sponsor
- Vice Chancellor for Research and Technology, Babol University of Medical Scenices
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 50
Inclusion Criteria
Patients with first occurrence of breast cancer
Exclusion criteria: Patients with concurrent chemoradiation; diabetes; collagen-vascular diseases; history of radiotherapy
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Dermatitis. Timepoint: Weekly. Method of measurement: According to RTOG scoring system.
- Secondary Outcome Measures
Name Time Method ocal adverse reactions. Timepoint: weekly. Method of measurement: physical exam.